Literature DB >> 618874

Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number.

O Lockridge, B N La Du.   

Abstract

Atypical and usual human serum cholinesterases were purified and studied with the fluorescent probe, N-methyl-(7-dimethylcarbamoxy)quinolinium iodide. Four active sites per tetramer were found in each enzyme. The turnover numbers of usual and atypical cholinesterases were the same: 15,000 mumol of benzoylcholine hydrolyzed/min/mumol of active site; 48,000 min-1 for o-nitrophenylbutyrate; and 0.0025 min-1 for N-methyl-(7-dimethylcarbamoxy)quinolinium iodide. They had identical rate constants for carbamylation, (5.0 min-1) and for decarbamylation (0.15 h-1). The major difference between the two genetically determined forms of the enzyme was substrate affinity, KD being 0.16 mM for usual and 5.4 mM for atypical cholinesterase, for the fluorescent probe substrate. Km for the uncharged ester, o-nitrophenylbutyrate, was 0.14 mM for both enzymes, whereas Km for benzoylcholine was 0.005 mM for usual and 0.024 mM for atypical cholinesterase. We interpret these data to mean that the two enzymes differ only in the structure of their anionic site.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 618874

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  The esterase-like activity of serum albumin may be due to cholinesterase contamination.

Authors:  N Chapuis; C Brühlmann; M Reist; P A Carrupt; J M Mayer; B Testa
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

2.  Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.

Authors:  P Masson; M T Froment; C F Bartels; O Lockridge
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features.

Authors:  Nir Waiskopf; Itzhak Shweky; Itai Lieberman; Uri Banin; Hermona Soreq
Journal:  ACS Chem Neurosci       Date:  2010-12-14       Impact factor: 4.418

Review 4.  Comparison of butyrylcholinesterase and acetylcholinesterase.

Authors:  A Chatonnet; O Lockridge
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

5.  DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

Authors:  C F Bartels; F S Jensen; O Lockridge; A F van der Spek; H M Rubinstein; T Lubrano; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

6.  Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.

Authors:  Max Zhan; Shurong Hou; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

7.  Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT----GGAG).

Authors:  C P Nogueira; M C McGuire; C Graeser; C F Bartels; M Arpagaus; A F Van der Spek; H Lightstone; O Lockridge; B N La Du
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

8.  Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.

Authors:  M C McGuire; C P Nogueira; C F Bartels; H Lightstone; A Hajra; A F Van der Spek; O Lockridge; B N La Du
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

9.  Changes in activity of non-specific esterases in cadmium treated Lymantria dispar larvae.

Authors:  Milena Vlahović; Vesna Perić Mataruga; Larisa Ilijin; Marija Mrdaković; Dejan Mirčić; Dajana Todorović; Jelica Lazarević
Journal:  Ecotoxicology       Date:  2011-10-09       Impact factor: 2.823

10.  Use of procainamide gels in the purification of human and horse serum cholinesterases.

Authors:  J S Ralston; A R Main; B F Kilpatrick; A L Chasson
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.